Halozyme Therapeutics (HALO)
(Delayed Data from NSDQ)
$58.53 USD
-0.71 (-1.20%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $58.40 -0.13 (-0.22%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $0.99 | -0.51% |
Earnings Summary
For their last quarter, Halozyme Therapeutics (HALO) reported earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.78 per share. This reflects a positive earnings surprise of 16.67%. Look out for HALO's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $0.99 per share, reflecting a year-over-year increase of 32%.
Earnings History
Price & Consensus
Zacks News for HALO
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
HALO: What are Zacks experts saying now?
Zacks Private Portfolio Services